Bloomberg @business
The FDA cleared a request to start human trials of Crispr gene-editing therapy to treat a rare swelling disorder https://t.co/Zdyb7oaAc5 — PolitiTweet.org
Created
Thu Mar 02 17:13:04 +0000 2023
Likes
14
Retweets
5
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Bloomberg @business
The FDA cleared a request to start human trials of Crispr gene-editing therapy to treat a rare swelling disorder https://t.co/Zdyb7oaAc5 — PolitiTweet.org